AI offers promise but faces barriers in drug development
Inertia is a barrier as is the traditional split between the clinical and the data-driven spheres of drug development. While smaller firms have an edge
Getting healthcare enterprise AI data to deliver
When we talk about artificial intelligence, the truth is most physicians aren’t using it.What we need now is for developers and tech executives to stop
Healthcare Artificial Intelligence Requires Data Access, Standards
December 01, 2020 - Data access and industry standards may help leaders eliminate potential bias in healthcare artificial intelligence tools, as well as improve implementation of
Artificial Intelligence in Health Care: Benefits and Challenges of Technologies to Augment Patient Care
What GAO Found Artificial Intelligence (AI) tools have shown promise for augmenting patient care in the following two areas: Clinical AI tools have shown promise
New Report “Artificial intelligence for Drug Discovery, Biomarker Development and Advanced R&D Landscape
Deep Pharma Intelligence Interactive mindmaps showing Pharmaceutical AI ecosystem at a glance Report by Deep Pharma Intelligence covers 240+ biotech companies, 600+ investors, 90+ corporations,
Pharma Industry Has A New Drug: Artificial Intelligence
by Priya Dialani December 11, 2020 0 comments AI-controlled platforms permit companies to change how they lead and screen clinical trials It’s almost difficult to
New project uses artificial intelligence in drug development
In health care, artificial intelligence is quite normal: it is used, for example, as an aid in making diagnoses. However, artificial intelligence is not yet
AI And Machine Learning In Healthcare: Garbage In, Garbage Out
Much proselytizing has occurred regarding the value and future of artificial intelligence (AI) and machine learning in healthcare. The industry is burgeoning. As with blockchain
Artificial Intelligence Platform Reduces Hospital Admissions By Over 50% In Trial
An artificial intelligence-based diagnostic tool has reduced hospital admissions by 51% among at-risk elderly patients, according to results of a trial released by the tool’s
Healthcare AI investment continues, but results are sluggish
A KLAS report released this week found that few organizations have settled on any particular artificial intelligence vendor as their choice going forward. Instead, said